Skip to main content

Table 2 Response according to RECIST 1.1 and Choi criteria. Data is represented as (n (%))

From: Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy

  

Response

Stable

Progression

3 months (n = 42)

RECIST 1.1

4 (9.5)

34 (81.0)

4 (9.5)

Choi

19 (45.2)

19 (45.2)

4 (9.5)

9 months (n = 39)

RECIST 1.1

5 (12.8)

26 (66.7)

8 (20.5)

Choi

17 (43.6)

13 (33.3)

9 (23.1)

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us